PetMed Express, Inc.
PETS
Positions held
Your positionsPETS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $27.75M | Enterprise value | $14.29M | Trailing P/E | — | Forward P/E | -42.67 |
| PEG | 2.32 | Price / book | 1.17 | Beta | 0.84 | Dividend yield | 0.00% |
| Revenue growth | -19.9% | Earnings growth | — | Gross margin | 27.9% | Operating margin | -15.2% |
| Profit margin | -17.3% | ROE | -78.6% | ROA | -20.0% | Debt / equity | 0.02 |
| Current ratio | 0.68 | Free cash flow | -$15.95M | Analyst recommendation | sell | Mean target | $1.40 |
| 52w high | $4.10 | 52w low | $1.27 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $41.0M | $42.8M | $40.7M | $44.4M | $51.2M |
| Op margin | -15.2% | -13.3% | -25.7% | -18.9% | -13.4% |
| Net income | -$6.1M | -$4.1M | -$10.6M | -$8.5M | -$34.2M |
| Gross margin | 27.6% | 32.6% | 23.3% | 28.0% | 28.1% |
| Gross profit | $11.3M | $13.9M | $9.5M | $12.4M | $14.4M |
| Operating income | -$6.2M | -$5.7M | -$10.5M | -$8.4M | -$6.9M |
- Revenue -4% vs prior quarter ($41M vs $43M).
- Gross margin 27.6% (was 32.6% prior quarter).
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $179M | — | $274M | $248M | $272M |
| Op margin | -17.5% | — | -3.0% | 2.4% | 8.9% |
| Net income | -$57.3M | — | -$7.5M | $5.1M | $18.7M |
| Gross margin | 28.1% | — | 30.9% | 30.9% | 28.3% |
| Gross profit | $50.2M | — | $84.8M | $76.5M | $76.9M |
| Operating income | -$31.4M | — | -$8.2M | $6.1M | $24.3M |
Headlines — watch
• [WARN · fundamentals] PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
News
2026-10-02 · PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-21 · PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
2026-09-17 · PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
2026-09-14 · PetMed Express Names Andrew Parry Chief Technology Officer
2026-09-14 · PetMeds Appoints Andrew Parry as Chief Technology Officer
2026-08-20 · PetMed Express (PETS) Q1 2027 Earnings Call Transcript
2026-08-14 · PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
2026-08-14 · PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ...
2026-08-14 · PetMed Express, Inc. Q1 2027 Earnings Call Summary
2026-08-13 · PetMed: Fiscal Q1 Earnings Snapshot
2026-08-13 · PetMeds® Announces First Quarter Financial Results
2026-07-30 · PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
Price (daily)
Full chart · RSI · MACD · patterns